Search

Home > Diabetes Discourse > Discussing a T2D Medication That Could Reduce Insulin Needs in T1D
Podcast: Diabetes Discourse
Episode:

Discussing a T2D Medication That Could Reduce Insulin Needs in T1D
Category: Science & Medicine
Duration: 00:00:00
Publish Date: 2023-11-27 05:00:00
Description: Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
Guest: David Selzer, MD

New research suggests that a GLP-1 receptor agonist medication, semaglutide, which has been approved for type 2 diabetes and obesity, could also be used to treat type 1 diabetes in patients. So what are the risks for patients who have type 1 diabetes and who are obese? Joining Dr. Mary Katherine Cheeley to discuss this is Dr. David Selzer, Clinical Instructor of Medicine at NYU Grossman School of Medicine and leads the Medical Weight Loss Program at NYU Langone Medical Associates in the Florida Division.

Total Play: 0

Some more Podcasts by ReachMD

200+ Episodes
Primary Care .. 50+     6
200+ Episodes
Focus on Neu .. 10+     3